These updates are republished press releases and communications from members of the Science|Business Network. Network Updates can be sent to [email protected] and [email protected]. To know if your content piece qualifies as Network Update, check the editorial guidelines here.

Finally, the market wakes up to resistance

Novartis’s move to take over UK biotech NeuTec Pharma at a large premium highlights how the so-called “superbugs” have reinvigorated pharma’s interest in antibiotics.